Moderna to supply Canadian government with 12 million doses of its bivalent COVID vaccine

moderna-to-supply-canadian-government-with-12-million-doses-of-its-bivalent-covid-vaccine

Moderna Inc. MRNA, -2.60% said Monday it will supply the Canadian government with 12 million doses of its bivalent COVID vaccine that targets the original virus and the omicron variant. The government has exercised an option to purchase 4.5 million doses and moved ahead with the scheduled delivery of 1.5 million doses from 2023 to 2022. Moderna has further agreed to convert six million doses of its COVID vaccine dubbed Spikevax to an omicron-containing bivalent vaccine, pending regulatory approval by the Canadian regulator. Shares were down 1.4% premarket and have fallen 42% in the year to date, while the S&P 500 SPX, -1.29% has fallen 11%.

Related Posts